4DMedical Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FDMDF research report →
About the company
4DMedical Limited operates as a medical technology firm with operations spanning both Australia and the United States. A core aspect of its business involves the commercialization of XV Technology, an advanced four-dimensional system for lung imaging. The company's offerings further extend to a software-as-a-service (SaaS) delivery model, alongside its proprietary XV lung ventilation analysis software.
- CEO
- Andreas Fouras
- IPO
- 2021
- Employees
- 145
- HQ
- Carlton, VIC, AU
Price Chart
- Market Cap
- $1.67B
- P/E
- -13.20
- P/S
- 586.44
- P/B
- -74.16
- EV/EBITDA
- -70.21
- Div Yield
- 0.00%
- Gross Margin
- -396.61%
- Op Margin
- -1166.28%
- Net Margin
- -3684.62%
- ROE
- -890.76%
- ROIC
- -37.27%
- Revenue
- $5.85M · 91.94%
- Net Income
- $-30,069,854 · 16.42%
- EPS
- $-0.07 · 35.55%
- Op Income
- $-29,220,394
- FCF YoY
- -10.88%
- 52W High
- $5.00
- 52W Low
- $0.16
- 50D MA
- $2.71
- 200D MA
- $2.34
- Beta
- 2.00
- Avg Volume
- 1.68K
Get TickerSpark's AI analysis on FDMDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FDMDF coverage
Recent articles, reports, and earnings notes.
No research on FDMDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FDMDF report →Similar companies
Peers in the same neighborhood.